BROWN UNIVERSITY

Johns Hopkins Medicine scientists found that 30 days in space weakened human bioengineered heart tissues, leading to reduced beating strength and irregular rhythms compared to Earth-bound samples. The study expands understanding of low gravity's effects on astronaut health and may aid in studying heart muscle aging and therapeutics on Earth.

Repare Therapeutics to present TRESR trial data on camonsertib monotherapy at ESMO Congress on Sept 14. The Phase 1/2 study aims to establish the recommended Phase 2 dose and evaluate safety, pharmacokinetics, and preliminary anti-tumor activity in patients with solid tumors.

Black stroke patients arrive at ERs 28 minutes later than white patients, increasing risk of death or disability. EMS is 20% less likely to notify hospitals ahead of Black patients' arrival, affecting treatment time. Delays are also seen in more deprived areas, highlighting systemic issues in EMS care.

Columbia University-led IndiPHARM project, funded by $39.5M from ARPA-H, aims to develop a platform measuring drugs, metabolites, and environmental factors to optimize therapeutic efficacy, reducing adverse drug events and improving patient care.

Joseph Edelman, Brown Corporation trustee and hedge fund manager, resigned publicly over Brown's upcoming divestment vote in October, citing concerns about antisemitism and Israel's destruction. Edelman, CEO of Perceptive Advisors, joined the board in 2019 and is a major donor to the University, funding research and human rights initiatives. His foundation has also donated to anti-trans advocacy groups.

Virginia Cancer Specialists, #1 in Virginia for cancer by Castle Connolly, expands its clinical research program with the addition of Dr. Neel Belani, enhancing patient care and access to novel therapies.

The U.S. bird flu outbreak in dairy cattle raises pandemic fears, with recent human cases linked to poultry farms. Scientists worry about the virus mutating to spread more easily among humans, despite current low risk. Research shows the virus can infect mammals more efficiently, highlighting the need for vigilant monitoring and containment efforts.